442 ICT01, an anti-BTN3A mAb that activates Vg9Vd2 T cells, plus interleukin-2: a potent and promising combination for cancer immunotherapy

by Jennifer Sims, Patrick Brune, René Hoet, Emmanuel Valentin, LE Suong, Sophie Agaugué, Paul Frohna
Published 2020-11-01

Patched Targeting Peptides for Imaging and Treatment of Hedgehog Positive Breast Tumors

by Daniel Smith, Fanlin Kong, David Yang, Richard Larson, Jennifer Sims-Mourtada, Wendy A. Woodward
Published 2014-01-01

687 Enhancement of anti-tumor immunity by ICT01: a novel g9d2 T cell-activating antibody targeting butyrophilin-3A (BTN3A)

by Jennifer Sims, Patrick Brune, René Hoet, Emmanuel Valentin, LE Suong, Sophie Agaugué, Remy Castellano, Alem Truneh
Published 2020-11-01

Enhancement of Arsenic Trioxide-Mediated Changes in Human Induced Pluripotent Stem Cells (IPS)

by Barbara Graham, Jacqueline Stevens, Phatia Wells, Jennifer Sims, Christian Rogers, Sophia S. Leggett, Stephen Ekunwe, Kenneth Ndebele
Published 2014-07-01

Detection of Canonical Hedgehog Signaling in Breast Cancer by 131-Iodine-Labeled Derivatives of the Sonic Hedgehog Protein

by Jennifer Sims-Mourtada, David Yang, Izabela Tworowska, Richard Larson, Daniel Smith, Ning Tsao, Lynn Opdenaker, Firas Mourtada, Wendy Woodward
Published 2012-01-01

465 Radiotherapy and CTLA-4 blockade expand anti-tumor T cells differentiation states and cooperate with CD40 agonist to induce tumor rejection

by Jennifer Sims, Erik Wennerberg, Claire Lhuillier, Maud Charpentier, Nils Rudqvist, Sheila Spada, Caroline Sheridan, Xi Kathy Zhou, Tuo Zhang, Alicia Alonso
Published 2020-11-01

Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High...

by Ebrahim S. Delpassand, Amin Samarghandi, Jennifer Sims Mourtada, Sara Zamanian, Gregory D. Espenan, Roozbeh Sharif, Shawn MacKenzie, Kambiz Kosari, Omar Barakat, Shagufta Naqvi, John E. Seng, Lowell Anthony
Published 2012-01-01